Analiz riska zdorovʹi͡u |
Pubbl/distr/stampa | Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) |
Soggetto topico |
Health risk assessment
Risk Assessment Public Health Environmental Health |
Soggetto genere / forma |
Periodicals.
Electronic journals. |
ISSN | 2308-1163 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | rus |
Altri titoli varianti | Health risk analysis |
Record Nr. | UNINA-9910162758403321 |
Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Analiz riska zdorovʹi͡u |
Pubbl/distr/stampa | Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) |
Soggetto topico |
Health risk assessment
Risk Assessment Public Health Environmental Health |
Soggetto genere / forma |
Periodicals.
Electronic journals. |
ISSN | 2308-1163 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | rus |
Altri titoli varianti | Health risk analysis |
Record Nr. | UNISA-996321743603316 |
Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Analiz riska zdorovʹi͡u |
Pubbl/distr/stampa | Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) |
Soggetto topico |
Health risk assessment
Risk Assessment Public Health Environmental Health |
Soggetto genere / forma | Periodicals. |
ISSN | 2308-1163 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | rus |
Altri titoli varianti | Health risk analysis |
Record Nr. | UNISA-996353348903316 |
Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Analiz riska zdorovʹi͡u |
Pubbl/distr/stampa | Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) |
Soggetto topico |
Health risk assessment
Risk Assessment Public Health Environmental Health |
Soggetto genere / forma | Periodicals. |
ISSN | 2308-1163 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | rus |
Altri titoli varianti | Health risk analysis |
Record Nr. | UNINA-9910410658403321 |
Permʹ : , : Federalʹnaiai͡a sluzhba po nadzoru v sfere zashchity prav potrebiteleĭ i blagopoluchii͡a cheloveka (Rospotrebnadzor) | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
Autore | Organization World Health |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
Descrizione fisica | 1 online resource (254 p.) |
Disciplina | 616 |
Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
Soggetto genere / forma |
Electronic books.
Publication Formats Technical Report |
ISBN | 92-4-069266-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
Record Nr. | UNINA-9910511992203321 |
Organization World Health
![]() |
||
Geneva, : World Health Organization, 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
Autore | Organization World Health |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
Descrizione fisica | 1 online resource (254 p.) |
Disciplina | 616 |
Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
Soggetto genere / forma |
Publication Formats
Technical Report |
ISBN | 92-4-069266-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
Record Nr. | UNINA-9910786624203321 |
Organization World Health
![]() |
||
Geneva, : World Health Organization, 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
Autore | Organization World Health |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
Descrizione fisica | 1 online resource (254 p.) |
Disciplina | 616 |
Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
Soggetto genere / forma |
Publication Formats
Technical Report |
ISBN | 92-4-069266-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
Record Nr. | UNINA-9910825162403321 |
Organization World Health
![]() |
||
Geneva, : World Health Organization, 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Applications of Toxicogenomics in Safety Evaluation and Risk Assessment [[electronic resource]] |
Autore | Boverhof Darrell R |
Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
Descrizione fisica | 1 online resource (402 p.) |
Disciplina |
616.042
616/.042 |
Altri autori (Persone) | GollapudiB. Bhaskar |
Soggetto topico |
Genetic toxicology
Health risk assessment Risk Assessment Toxicity testing Toxicogenetics Toxicology Pharmacogenetics Risk Risk Management Epidemiologic Measurements Organization and Administration Pharmacology Probability Genetics Public Health Health Occupations Statistics as Topic Biological Science Disciplines Biology Health Services Administration Environment and Public Health Natural Science Disciplines Health Care Health Care Evaluation Mechanisms Epidemiologic Methods Quality of Health Care Investigative Techniques Health Care Quality, Access, and Evaluation Health & Biological Sciences Toxicology & Public Health |
Soggetto genere / forma | Electronic books. |
ISBN |
1-283-23966-3
9786613239662 1-118-00104-4 1-118-00103-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Contents; Preface; Contributors; 1 Toxicology, ""Omics"" Technologies, and Toxicogenomics: A Primer; 2 Introduction to Human Health Risk Assessment; 3 Practical Considerations for the Application of Toxicogenomics to Risk Assessment: Early Experience, Current Drivers, and a Path Forward; 4 Approaches and Practical Considerations for the Analysis of Toxicogenomics Data; 5 Genomics in Identifying Mutagenic Mode of Action in Carcinogenesis; 6 Application of Genomics for Predicting and Understanding the Mode of Action for Nongenotoxic Carcinogens; 7 Genomics in Characterizing Endocrine Toxicity
8 Studying Organ-Specific Toxicity Using Gene-Expression Profiling9 Toxicogenomic Studies in Human Populations; 10 Toxicogenomics Applied to Ecological Risk Assessment; 11 Analysis of Transcriptomic Dose-Response Data for Toxicology and Risk Assessment; 12 Toxicogenomics as a Tool for Validating Animal to Human Extrapolations in Chemical Risk Assessment: Concepts, Applications, and Challenges; 13 Toxicogenomics and Animal Alternatives; 14 Toxicogenomics and the Regulatory Framework; 15 Standardization of Gene-Expression Information for the Safety Evaluation: Activities in Japan 16 Applying Transcriptional Profiling in Drug Safety Evaluation17 Reframing the Risk Assessment Paradigm: Toward a Systems Biology Approach; Index |
Record Nr. | UNINA-9910139607903321 |
Boverhof Darrell R
![]() |
||
Hoboken, : Wiley, 2011 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Applications of Toxicogenomics in Safety Evaluation and Risk Assessment [[electronic resource]] |
Autore | Boverhof Darrell R |
Edizione | [First edition.] |
Pubbl/distr/stampa | Hoboken : , : Wiley, , 2011 |
Descrizione fisica | 1 online resource (402 pages) |
Disciplina |
616.042
616/.042 |
Altri autori (Persone) | GollapudiB. Bhaskar |
Soggetto topico |
Genetic toxicology
Health risk assessment Risk Assessment Toxicity testing Toxicogenetics Toxicology Pharmacogenetics Risk Risk Management Epidemiologic Measurements Organization and Administration Pharmacology Probability Genetics Public Health Health Occupations Statistics as Topic Biological Science Disciplines Biology Health Services Administration Environment and Public Health Natural Science Disciplines Health Care Health Care Evaluation Mechanisms Epidemiologic Methods Quality of Health Care Investigative Techniques Health Care Quality, Access, and Evaluation Health & Biological Sciences Toxicology & Public Health |
ISBN |
1-283-23966-3
9786613239662 1-118-00104-4 1-118-00103-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Contents; Preface; Contributors; 1 Toxicology, ""Omics"" Technologies, and Toxicogenomics: A Primer; 2 Introduction to Human Health Risk Assessment; 3 Practical Considerations for the Application of Toxicogenomics to Risk Assessment: Early Experience, Current Drivers, and a Path Forward; 4 Approaches and Practical Considerations for the Analysis of Toxicogenomics Data; 5 Genomics in Identifying Mutagenic Mode of Action in Carcinogenesis; 6 Application of Genomics for Predicting and Understanding the Mode of Action for Nongenotoxic Carcinogens; 7 Genomics in Characterizing Endocrine Toxicity
8 Studying Organ-Specific Toxicity Using Gene-Expression Profiling9 Toxicogenomic Studies in Human Populations; 10 Toxicogenomics Applied to Ecological Risk Assessment; 11 Analysis of Transcriptomic Dose-Response Data for Toxicology and Risk Assessment; 12 Toxicogenomics as a Tool for Validating Animal to Human Extrapolations in Chemical Risk Assessment: Concepts, Applications, and Challenges; 13 Toxicogenomics and Animal Alternatives; 14 Toxicogenomics and the Regulatory Framework; 15 Standardization of Gene-Expression Information for the Safety Evaluation: Activities in Japan 16 Applying Transcriptional Profiling in Drug Safety Evaluation17 Reframing the Risk Assessment Paradigm: Toward a Systems Biology Approach; Index |
Record Nr. | UNINA-9910824275603321 |
Boverhof Darrell R
![]() |
||
Hoboken : , : Wiley, , 2011 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Assessment and Reclamation of Contaminated Land [[electronic resource]] |
Autore | Harrison Roy M. <1948-> |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Cambridge, : Royal Society of Chemistry, 2001 |
Descrizione fisica | 1 online resource (180 p.) |
Disciplina | 628.55 |
Altri autori (Persone) |
HesterR. E
PollardS.imon |
Collana | Issues in Environmental Science and Technology |
Soggetto topico |
Reclamation of land -- Great Britain
Soil pollution -- Great Britain Soil pollution -- Law and legislation -- Great Britain Soil remediation -- Great Britain Soil pollution - Law and legislation - Great Britain Soil pollution - Great Britain Soil remediation - Great Britain Reclamation of land - Great Britain Risk Management Risk Epidemiologic Measurements Environmental Pollutants Public Health Probability Toxic Actions Organization and Administration Statistics as Topic Chemical Actions and Uses Environment and Public Health Health Services Administration Health Care Epidemiologic Methods Health Care Evaluation Mechanisms Investigative Techniques Quality of Health Care Health Care Quality, Access, and Evaluation Soil Pollutants Risk Assessment Civil & Environmental Engineering Engineering & Applied Sciences Environmental Engineering |
ISBN |
1-84755-017-7
1-59124-419-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CONTENTS; The Extent of Contaminated Land Problems and the Scientific Response; 1 The Origins of Contaminated Land Problems; 2 The Extent of the Challenge; 3 Developments in the Science Base; 4 Conclusions; 5 Acknowledgements; The New UK Contaminated Land Regime; 1 Introduction; 2 The Context forPart IIA; 3 The Part IIA System; 4 Dealing with 'Risk'; 5 Making People Pay; 6 Part IIA as a 'Regulatory System'; 7 The State of Play; 8 What Next?; Identifying and Dealing with Contaminated Land; 1 Introduction; 2 Site Assessment; 3 Risk Management; 4 Measurement of Site Contamination; 5 Conclusions
Contaminated Land and the Link with Health1 Introduction; 2 Exposure; 3 Health Studies; 4 Case Studies; 5 Conclusion; Human Health Risk Assessment: Guideline Values and Magic Numbers; 1 Land Contamination Policy; 2 Risk Assessment; 3 What Is a Guideline Value?; 4 The Use of Guideline Values; 5 The CLEA Model; 6 The SNIFFER Framework; 7 Conclusions; 8 Acknowledgements; Ecological Risk Assessment under the New Contaminated Land Regime; 1 Background and Legal Context; 2 Harm to Ecological Receptors; 3 General Approach to the Assessment of Land Under the NewRegime 4 Assessing Whether Significant Harm to Ecological Receptors Is Occurring5 Assessing the Possibility of Significant Harm Occurring; 6 The Environment Agency's Suggested Approach; 7 Guideline Values; 8 Comments and Discussion; Remediation Methods for Contaminated Sites; 1 Introduction; 2 Summary of Remediation Approaches; 3 Selected Innovative Approaches; 4 Summary and Conclusions; Legal Liabilities and Insurance Aspects of Contaminated Land; 1 Introduction; 2 Contaminated Land; 3 Statutory Provisions in the UK; 4 Sale of Land/Businesses; 5 Principles of Insurance 6 History of Environmental Insurance7 Land Owners and Environmental Liabilities; 8 Pollution Liabilities for Contaminated Land Sites; 9 Current Manufacturing Activities; 10 Environmental Insurance; 11 Environmental Consultants; 12 Collateral Warranties; 13 Contractors; 14 An Example; 15 Conclusion; Subject Index |
Record Nr. | UNINA-9910142515703321 |
Harrison Roy M. <1948->
![]() |
||
Cambridge, : Royal Society of Chemistry, 2001 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|